What does a low free thyroxine (T4) level with a normal thyroid‑stimulating hormone (TSH) level indicate, and what are the appropriate next steps for evaluation and management?

Low Free T4 with Normal TSH: Central Hypothyroidism Until Proven Otherwise

A free T4 of 0.326 ng/dL (assuming units) with a normal TSH of 1.28 mIU/L is consistent with central (secondary) hypothyroidism and requires immediate evaluation for pituitary dysfunction, including assessment for hypophysitis and other pituitary hormone deficiencies. 1

Understanding the Pattern

This combination of low free T4 with normal TSH indicates the pituitary is failing to appropriately increase TSH production in response to low thyroid hormone levels. 1

• In central hypothyroidism, TSH can remain within the reference range despite inadequate thyroid hormone production, making this pattern particularly important to recognize 1
• The normal feedback mechanism is disrupted at the pituitary or hypothalamic level 1

Critical Next Steps

Immediate Evaluation Required

1. Assess for hypophysitis and other pituitary hormone deficiencies:

• Measure morning (8 AM) cortisol and ACTH simultaneously 1
• Check other pituitary axes: LH, FSH, prolactin, IGF-1 1
• This is critical because if cortisol is low, hydrocortisone must be given BEFORE thyroid hormone replacement to prevent adrenal crisis 1

2. Obtain pituitary imaging:

• MRI of the pituitary with and without contrast 1
• Look for pituitary mass, hypophysitis, or structural abnormalities 1

3. Review medication history:

• Check for immune checkpoint inhibitors (ipilimumab, nivolumab, pembrolizumab) 1
• Review other medications that can affect pituitary function 1

Clinical Context Matters

Assess for symptoms of hypothyroidism:

• Fatigue, cold intolerance, weight gain, constipation, bradycardia 1
• Mental status changes, hypothermia (concerning for myxedema) 1

Look for symptoms suggesting multiple pituitary hormone deficiencies:

• Headache, visual field defects (mass effect) 1
• Hypotension, hyponatremia (adrenal insufficiency) 1
• Amenorrhea, decreased libido (gonadotropin deficiency) 1

Management Algorithm

If Symptomatic or Severe (G3-4):

• Endocrine consultation immediately 1
• If uncertainty exists about adrenal function, give hydrocortisone BEFORE initiating thyroid hormone 1
• Consider hospital admission if myxedema features present (bradycardia, hypothermia, altered mental status) 1
• Initiate levothyroxine replacement after ensuring adequate cortisol 1

If Asymptomatic or Mild Symptoms (G1-2):

• Endocrine consultation for unusual presentations and central hypothyroidism 1
• Complete pituitary hormone evaluation before treatment 1
• Begin thyroid hormone replacement guided by free T4 levels, NOT TSH 2, 3

Treatment Considerations for Central Hypothyroidism

TSH cannot be used to monitor therapy in central hypothyroidism 2, 3

• Target free T4 levels in the upper half of the reference range 2
• Patients with central hypothyroidism require higher free T4 levels (mean 1.31 ng/dL) compared to euthyroid controls (mean 1.10 ng/dL) 2
• Monitor using free T4 and free T3 concentrations, not TSH 3

Dosing approach:

• For patients <70 years without cardiac disease: full replacement at approximately 1.6 mcg/kg/day 1
• For patients >70 years or with cardiac disease: start with 25-50 mcg and titrate up 1

Common Pitfalls to Avoid

Critical error: Starting thyroid hormone before ensuring adequate cortisol replacement 1

• Thyroid hormone increases cortisol metabolism and can precipitate adrenal crisis 1
• Always check morning cortisol and ACTH before initiating levothyroxine 1

Do not rely on TSH for diagnosis or monitoring:

• TSH remains normal in many cases of central hypothyroidism 1
• TSH is unreliable for monitoring treatment adequacy 2, 3

Do not dismiss borderline low free T4 values:

• Even free T4 values between 0.67-0.89 ng/dL with normal TSH warrant investigation 4
• However, values ≥0.89 ng/dL often have normal free T4 index and may not represent true hypothyroidism 4

Special Considerations

If on immune checkpoint inhibitor therapy:

• This pattern is consistent with hypophysitis, most common with ipilimumab 1
• May continue immunotherapy with appropriate hormone replacement 1
• Monitor thyroid function every 4-6 weeks 1

Distinguish from assay interference:

• Repeat testing to confirm abnormal results 1
• Consider free T4 index if immunoassay results are borderline 4